대식세포 활성화 조절을 통한 atorvastatin의 항천식 효과
Antiasthmatic effect of atorvastatin via modulation of macrophage activation
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Asthma is a chronic airway inflammatory disorder and is associated with macrophages. Statin, a well-known lipid-lowering agent, has recently been noted for its anti-inflammatory effect on macrophage. This study was designed to evaluate the antiasthmatic effect of atorvastatin via modulation of macrophage activation by using an animal model of allergic asthma. Methods: Atorvastatin 40 mg/kg was given by gavage once a day for 3 days before challenge of ovalbumin (OVA); airway hyperresponsiveness (AHR), airway inflammatory cells, and cytokines were evaluated in the murine asthma model. The direct effect of atorvastatin on the activation of macrophages in vitro was determined using the alveolar macrophage cell line CRL-2456. Results: Administration of atorvastatin reduced the numbers of total inflammatory cells, macrophages, and eosinophils as well as lung histology enhanced in the murine asthma model. AHR measured by enhanced pause was significantly reduced after atorvastatin administration in the murine asthma model (P<0.05). Atorvastatin administration resulted in the reduction in serum OVA-specific IgE levels and the increase in serum OVA-specific IgG2a levels (P<0.05). The mRNA levels of Ccr3, Il-17, and Muc5ac enhanced by OVA challenge were decreased by treatment with atorvastatin (P<0.05). Along with these improvement in allergic inflammatory changes, the population of CD11c–CD206+ macrophages as well as the expression of Ym-1 and Relm-α in the lungs were reduced with atorvastatin (P<0.05). In vitro test with CRL-2456 showed that atorvastatin reduced the expression of Cd206, Arg-1, and Fgf-2 induced by IL-4 stimulation (P<0.05). Conclusion: This study highlighted the antiasthmatic effect of atorvastatin on the suppression of M2 macrophage activation in allergic asthma.
Abstract
Purpose: Asthma is a chronic airway inflammatory disorder and is associated with macrophages. Statin, a well-known lipid-lowering agent, has recently been noted for its anti-inflammatory effect on macrophage. This study was designed to evaluate the antiasthmatic effect of atorvastatin via modulation of macrophage activation by using an animal model of allergic asthma. Methods: Atorvastatin 40 mg/kg was given by gavage once a day for 3 days before challenge of ovalbumin (OVA); airway hyperresponsiveness (AHR), airway inflammatory cells, and cytokines were evaluated in the murine asthma model. The direct effect of atorvastatin on the activation of macrophages in vitro was determined using the alveolar macrophage cell line CRL-2456. Results: Administration of atorvastatin reduced the numbers of total inflammatory cells, macrophages, and eosinophils as well as lung histology enhanced in the murine asthma model. AHR measured by enhanced pause was significantly reduced after atorvastatin administration in the murine asthma model (P<0.05). Atorvastatin administration resulted in the reduction in serum OVA-specific IgE levels and the increase in serum OVA-specific IgG2a levels (P<0.05). The mRNA levels of Ccr3, Il-17, and Muc5ac enhanced by OVA challenge were decreased by treatment with atorvastatin (P<0.05). Along with these improvement in allergic inflammatory changes, the population of CD11c–CD206+ macrophages as well as the expression of Ym-1 and Relm-α in the lungs were reduced with atorvastatin (P<0.05). In vitro test with CRL-2456 showed that atorvastatin reduced the expression of Cd206, Arg-1, and Fgf-2 induced by IL-4 stimulation (P<0.05). Conclusion: This study highlighted the antiasthmatic effect of atorvastatin on the suppression of M2 macrophage activation in allergic asthma.
참고문헌 (39)
- Murdoch JR, "Chronic inflammation and asthma", Mutat Res, 690, pp.24~39 (2010)
- Platts-Mills TA, "The role of immunoglobulin E in allergy and asthma", Am J Respir Crit Care Med, 164, pp.S1~S5 (2001)
- Kips JC, "Cytokines in asthma", Eur Respir J Suppl, 34, pp.24s~33s (2001)
- Muraille E, "TH1", TH2 paradigm extended : macrophage polarization as an unappreciated pathogen-driven escape mechanism, 2014, pp.5, 603~
- Saradna A, "Macrophage polarization and allergic asthma", Transl Res, 191, pp.1~14 (2018)
- Martinez FO, "Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages : similarities and differences", Blood, 121, pp.e57~e69 (2013)
- Zhu Z, "Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation", Science, 304, pp.1678~1682 (2004)
- Fricker M, "Macrophage dysfunction in the pathogenesis and treatment of asthma", Eur Respir J, 50, pp.1700196~ (2017)
- Stancu C, "Statins : mechanism of action and effects", J Cell Mol Med, 5, pp.378~387 (2001)
- Kim DY, "Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model", Eur J Pharmacol, 557, pp.76~86 (2007)
- Balli U, "Assessment of vascular endothelial growth factor and matrix metalloproteinase-9in the periodontium of rats treated with atorvastatin", J Periodontol, 85, pp.178~187 (2014)
- McKay A, "A novel antiinflammatory role of simvastatin in a murine model of allergic asthma", J Immunol, 172, pp.2903~2908 (2004)
- Xu WH, "Repetitive measurements of enhanced pause(Penh)", Respir Physiol Neurobiol, 206, pp.41~44 (2015)
- Coward WR, "Statin-in-duced proinflammatory response in mitogen-activated peripheral blood mononuclear cells through the activation of caspase-1 and IL-18 secretion in monocytes", J Immunol, 176, pp.5284~5292 (2006)
- Wynn TA, "Macrophage biology in development, homeostasis and disease", Nature, 496, pp.445~455 (2013)
- Lavin Y, "Regulation of macrophage development and function in peripheral tissues", Nat Rev Immunol, 15, pp.731~744 (2015)
- Davies LC, "Tissue-resident macrophages", Nat Immunol, 14, pp.986~995 (2013)
- Chakarov S, "Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches", Science, 363, pp.eaau0964~ (2019)
- Gibbings SL, "Three Unique Interstitial Macrophages in the Murine Lung at Steady State", Am J Respir Cell Mol Biol, 57, pp.66~76 (2017)
- Ural BB, "Identification of a nerve-associated, lung-resident interstitial macrophage subset with distinct localization and immunoregulatory properties", Sci Immunol, 5, pp.eaax8756~ (2020)
- Girodet PO, "Alternative macrophage activation is increased in asthma", Am J Respir Cell Mol Biol, 55, pp.467~475 (2016)
- Draijer C, "Human asthma is characterized by more IRF5+ M1 and CD206+ M2 macrophages and less IL-10+ M2-like macrophages around airways compared with healthy airways", J Allergy Clin Immunol, 140, pp.280~283 (2017)
- Shim JS, "Aggravation of asthmatic inflammation by chlorine exposure via innate lymphoid cells and CD11c(intermediate)macrophages", Allergy, 75, pp.381~391 (2020)
- Lee HS, "Thalidomide inhibits alternative activation of macrophages in vivo and in vitro : a potential mechanism of anti-asthmatic effect of thalidomide", PLoS One, 10, pp.e0123094~ (2015)
- Kim J, "Innate immune crosstalk in asthmatic airways : innate lymphoid cells coordinate polarization of lung macrophages", J Allergy Clin Immunol, 143, pp.1769~1782 (2019)
- Huang CC, "Statin use in patients with asthma : a nationwide population-based study", Eur J Clin Invest, 41, pp.507~512 (2011)
- Zeki AA, "Statin use and asthma control in patients with severe asthma", BMJ Open, 3, pp.e003314~ (2013)
- Tse SM, "Statin exposure is associated with decreased asthma-related emergency department visits and oral corticosteroid use", Am J Respir Crit Care Med, 188, pp.1076~1082 (2013)
- Rosenberg JL, "Antilipid agents may provide allergy protection", Ann Allergy Asthma Immunol, 110, pp.1~ (2013)
- Huang CF, "Effect of oral administration with pravastatin and atorvastatin on airway hyperresponsiveness and allergic reactions in asthmatic mice", Ann Allergy Asthma Immunol, 110, pp.11~17 (2013)
- Imamura M, "Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitisation, interleukin 17 production and antigen presentation in the lung", Thorax, 64, pp.44~49 (2009)
- Firinci F, "The effect of atorvastatin on lung histopathology in a murine model of chronic asthma", Allergol Immunopathol(Madr), 42, pp.355~361 (2014)
- Liu MW, "Atorvastatin has a protective effect in a mouse model of bronchial asthma through regulating tissue transglutaminase and triggering receptor expressed on myeloid cells-1 expression", Exp Ther Med, 14, pp.917~930 (2017)
- Kamal AHM, "Inflammatory Proteomic Network Analysis of Statin-treated and Lipopolysaccharide-activated Macrophages", Sci Rep, 8, pp.164~ (2018)
- Croons V, "Effect of statins on the viability of macrophages and smooth muscle cells", J Cardiovasc Pharmacol, 55, pp.269~275 (2010)
- Hothersall EJ, "Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma", Thorax, 63, pp.1070~1075 (2008)
- Maneechotesuwan K, "Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase", J Allergy Clin Immunol, 126, pp.754~762 (2010)
- Sakamoto N, "Effect of atorvastatin on PM10-induced cytokine production by human alveolar macrophages and bronchial epithelial cells", Int J Toxicol, 28, pp.17~23 (2009)
- Yao Y, "Macrophage polarization in physiological and pathological pregnancy", Front Immunol, 10, pp.792~ (2019)
